In contrast, the CN profiles of the 16 BRCA2 breast cancers with bi-allelic inactivation were more similar to those of the PALB2-associated breast cancers, albeit more frequently harboring losses of 13q and 22q, among other differences (P < 0.05; Supplementary Fig. 5b). This evidence concerns the gene BRCA2 and breast carcinoma.